Ohki I, Dan K, Kuriya S, Nomura T
Third Department of Internal Medicine, Nippon Medical School, Tokyo, Japan.
Jpn J Med. 1988 May;27(2):155-9. doi: 10.2169/internalmedicine1962.27.155.
To elucidate the mechanism of anemia and leukopenia in the patients with liver cirrhosis, we investigated hematopoietic progenitor cell contents in their bone marrow, and the effects of their sera and blood mononuclear cells on hematopoietic progenitors from normal subjects. While there was no significant difference in the number of marrow CFU-E and BFU-E between the patients with liver cirrhosis and normal subjects, the number of marrow CFU-C was significantly reduced in liver cirrhosis patients. Patients' sera suppressed in vitro colony formation of normal CFU-E, BFU-E, and CFU-C, and the degree of suppression was well correlated with severity of anemia or granulocytopenia. In vitro colony formation of normal hematopoietic progenitor cells was not affected by blood mononuclear cells from liver cirrhosis patients. These results indicate that the appearance of humoral inhibitor(s) of hematopoietic progenitors plays a role in the development of anemia and granulocytopenia in liver cirrhosis.
为阐明肝硬化患者贫血和白细胞减少的机制,我们研究了他们骨髓中造血祖细胞的含量,以及他们的血清和血液单核细胞对正常受试者造血祖细胞的影响。虽然肝硬化患者与正常受试者之间骨髓CFU-E和BFU-E的数量没有显著差异,但肝硬化患者骨髓CFU-C的数量显著减少。患者血清抑制正常CFU-E、BFU-E和CFU-C的体外集落形成,抑制程度与贫血或粒细胞减少的严重程度密切相关。肝硬化患者的血液单核细胞不影响正常造血祖细胞的体外集落形成。这些结果表明,造血祖细胞体液抑制剂的出现参与了肝硬化患者贫血和粒细胞减少的发生。